GLUE icon

Monte Rosa Therapeutics

71 hedge funds and large institutions have $227M invested in Monte Rosa Therapeutics in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

0% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 13

4.9% less ownership

Funds ownership: 85.14%80.24% (-4.9%)

40% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 25

Holders
71
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.9M
Puts
$1.24M
Net Calls
Net Calls Change

Top Buyers

1 +$6.05M
2 +$865K
3 +$717K
4
CM
Caption Management
Oklahoma
+$512K
5
Jane Street
Jane Street
New York
+$400K

Top Sellers

1 -$7.47M
2 -$3.89M
3 -$2.64M
4
ECM
ExodusPoint Capital Management
New York
-$2.2M
5
Northern Trust
Northern Trust
Illinois
-$899K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$43.5M
2
$31.3M
3
$27.9M
4
$27.8M
5
$25.6M
6
$13.4M
7
$8.97M
8
$8.32M
9
$8.27M
10
$5.56M
11
$3.89M
12
$3.24M
13
$2.89M
14
$1.61M
15
$1.39M
16
$1.3M
17
$1.09M
18
$921K
19
$763K
20
$594K
21
$591K
22
$568K
23
$512K
24
$503K
25
$456K